glp-1 trump deal Eli Lilly and Novo Nordisk are lowering drug costs thanks to a new with President Trump. 💉 KTSM - The Trump administration

Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR

These treatments have a wide variety of benefits, from cleansing your body of toxins to supporting weight loss, to improving your skin

In Phase 3 studies: Participants without diabetes taking orforglipron lost approximately 9% to 10% of body weight over roughly 36 to 40 weeks Participants with type 2 diabetes generally lost around 7% to 8% By comparison, Wegovy's landmark STEP trials reported approximately 14.9% average weight loss over 68 weeks

This warning stems from studies in rodents where these medications caused dose-dependent and treatment-duration-dependent increases in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), at clinically relevant exposures

In the animal model, treatment with GS led to reduced mRNA stability of the preproglucagon gene, the precursor of glucagon-like peptide-1 (GLP-1), decreasing its concentration [14]